1. Breast cancer statistics, 2011;De Santis;CA Cancer J Clin,2011
2. Ferlay J, Soerjomataram I, Ervik M, et al. Cancer incidence and mortality worldwide: IARC CancerBase. GLOBOCAN 2012 v1. 0. 2013. Available at: http://globocan.iarc.fr.
3. A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer;Yardley;Clin Breast Cancer,2010
4. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Cancer,2009
5. Obesity and cancer mechanisms underlying tumour progression and recurrence;Park;Nat Rev Endocrinol,2014